Progress in psoriasis. Psoriasis: from gene to clinic. London, UK, 5-7 December 1996.
In a meeting dedicated to a single common complex disease such as psoriasis, it is not surprising that many unanswered questions were raised. However, the meeting highlighted the impressive progress being made in psoriasis research at both the investigative and the therapeutic levels. A follow-up meeting is to take place in 1999, when further characterization of susceptibility gene loci should be available, together with data concerning the selective nature of disease-causing T cells and the antigens that trigger the disease. Identification of these critical factors should allow development of highly specific therapeutic agents, some of which are beginning to find their way into clinical development.
Barker
J N
JN
St John's Institute of Dermatology, Guy's Medical and Dental School, London, UK.
Griffiths
C E
CE
D002454:Cell Differentiation; D002455:Cell Division; D020022:Genetic Predisposition to Disease; D006801:Humans; D007167:Immunotherapy; D011565:Psoriasis / Q000473:pathology / Q000503:physiopathology* / Q000628:therapy*; D012867:Skin / Q000473:pathology